Background/Objectives: Knee osteoarthritis (KOA) accounts for about 35% of the arthritis burden among adults. Most adults with KOA
have slowly-progressing, common knee osteoarthritis (CKOA); however, some individuals experience accelerated KOA (AKOA), rapid
progression to end-stage disease within 48 months. This study analyzed individuals without radiographic evidence of KOA at baseline
to determine which (baseline) characteristics were associated with progression to CKOA and/or AKOA status 48 months later.
Methods Data (n = 1,561) from the Osteoarthritis Initiative (OAI) were utilized. Multinomial logistic regression was employed to determine the magnitude of association between baseline risk factors and 48-month KOA status (AKOA and CKOA, compared to no KOA).
Results Older age (p = 0.032), greater baseline BMI (p < 0.001), female gender (p = 0.009), and greater baseline PASE score (p =
0.036) were significantly associated with CKOA (11.9% of participants) and/or AKOA (3.5% of participants) at 48 months. Age, BMI, and
PASE were all more strongly associated with greater risk of AKOA compared to risk of CKOA (Age: OR = 1.59 vs. 0.97; BMI: OR = 1.62
vs. 1.28; PASE: OR = 1.21 vs. 1.08). Of these, only BMI was significantly associated with greater risk of both AKOA and CKOA.
Conclusion Certain factors impact the risk of AKOA and CKOA differently. Age did not increase the risk of CKOA, but among those
with CKOA or AKOA, the proportion with AKOA increased with age. Thus, older age at onset is associated with more rapid KOA progression.
Keywords Age; osteoarthritis; accelerated knee osteoarthritis; common knee osteoarthritis
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.